Form 4: Vor Biopharma Executive Chakraborty Sells Shares to Cover Tax Obligations

Tirtha Chakraborty, Chief Scientific Officer & Head of Technical Operations at Vor Biopharma, sold 876 shares of common stock on May 6, 2025, to cover tax obligations related to the settlement of restricted stock units.

Summary

• On May 6, 2025, Tirtha Chakraborty, the Chief Scientific Officer & Head of Technical Operations at Vor Biopharma Inc., disposed of 876 shares of common stock.
• The transaction was executed to satisfy tax withholding obligations related to the settlement of restricted stock units.
• The shares were sold at a price of $0.56 per share.
• Following the transaction, Chakraborty directly owns 217,416 shares of Vor Biopharma Inc. common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing related to an insider stock transaction for tax purposes, indicating a neutral sentiment.

Industry Context

Form 4 filings are a routine part of the financial markets, providing transparency into the transactions of company insiders. This particular filing indicates a sale of shares to cover tax obligations, which is a common practice.

Stakeholder Impact

• The sale of shares by an insider could have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's operations or financial condition.

Key Dates

Keywords

Form 4, VOR, Vor Biopharma, Chakraborty, Insider Trading, Stock Sale, Tax Obligations, Restricted Stock Units